Who owns ADIAL PHARMACEUTICALS INC?
- Ticker: ADIL
- CUSIP Number: 00688a205
Tip: Access positions for across all investors
Analyze quarterly positions in Adial Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Adial Pharmaceuticals stock
Who bought or sold ADIAL PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 164k | $58k | 138% | Sep 2025 |
|
| Vanguard Group | 156k | $55k | 1086% | Sep 2025 |
|
| Citadel Advisors | 144k | $51k | 100% | Sep 2025 |
|
| Manchester Capital Management | 48k | $17k | 0% | Sep 2025 |
|
| BlackRock | 28k | $9.8k | 0% | Sep 2025 |
|
| UBS Group | 19k | $6.6k | 51% | Sep 2025 |
|
| Two Sigma Securities | 13k | $4.5k | 100% | Sep 2025 |
|
| Jane Street | 12k | $4.4k | -50% | Sep 2025 |
|
| Hrt Financial | 11k | $3.0k | -41% | Sep 2025 |
|
| Private Management Group | 10k | $3.5k | 100% | Sep 2025 |
|
| SBI Securities | 1.4k | $493.067200 | 6% | Sep 2025 |
|
| Tower Research Capital | 1.4k | $484.021000 | -3% | Sep 2025 |
|
| Wells Fargo & Company | 160.00 | $56.992000 | 0% | Sep 2025 |
|
| Abound Wealth Management | 27.00 | $10.000800 | 0% | Sep 2025 |
|
| Morgan Stanley | 9.00 | $2.999700 | 100% | Jun 2025 |
|
Who sold out of Adial Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Investments | Jun 2025 | 11k | $3.3k |
| Stone House Investment Management | Jun 2025 | 2.7k | $815.940000 |